Search Count: 21
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.89 Å Release Date: 2024-07-10 Classification: RNA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-07-10 Classification: RNA Ligands: ACT, EDO, CA |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME Ligands: MG, NAD, SPM, SRY, K, ZN, FES, ATP, GNP |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME Ligands: NAD, MG, K, ZN, FES, ATP, GDP, SAH |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME Ligands: NAD, SPM, SRY, MG, K, ZN, FES, ATP, GNP |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME Ligands: NAD, SPM, SRY, MG, K, ZN, FES, ATP, GNP, FME, GTP |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: RIBOSOME Ligands: ZN, MG, PNS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-05-03 Classification: TRANSCRIPTION Ligands: TRS, KUR |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2023-05-03 Classification: TRANSCRIPTION Ligands: KUI |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2023-05-03 Classification: TRANSCRIPTION Ligands: KTF, TRS |
 |
Cdk2 In Complex With Cpd14 (5-Fluoro-4-(4-Methyl-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A]Azepin-3-Yl)-N-(5-(4-Methylpiperazin-1-Yl)Pyridin-2-Yl)Pyrimidin-2-Amine)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-07-29 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: N14 |
 |
Cdk6 In Complex With Cpd13 (R)-5-Fluoro-4-(4-Methyl-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A]Azepin-3-Yl)-N-(5-(4-Methylpiperazin-1-Yl)Pyridin-2-Yl)Pyrimidin-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.71 Å Release Date: 2020-07-29 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: N1A |
 |
Cdk6 In Complex With Cpd24 N-(5-(6-Ethyl-2,6-Diazaspiro[3.3]Heptan-2-Yl)Pyridin-2-Yl)-5-Fluoro-4-(4-Methyl-5,6,7,8-Tetrahydro-4H-Pyrazolo[1,5-A]Azepin-3-Yl)Pyrimidin-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2020-07-29 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: N1J |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.50 Å Release Date: 2013-05-08 Classification: RNA BINDING PROTEIN Ligands: SO4 |
 |
Structure Of The Star (Signal Transduction And Activation Of Rna) Domain Of Gld-1 Bound To Rna
Organism: Caenorhabditis elegans
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2013-05-08 Classification: RNA BINDING PROTEIN |
 |
Crystal Structure Of The Therapeutical Antibody Fragment Of Canakinumab In Its Unbound State
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2012-12-19 Classification: IMMUNE SYSTEM |
 |
Crystal Structure Of Human Il-1Beta In Complex With The Therapeutic Antibody Binding Fragment Of Canakinumab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2012-12-19 Classification: IMMUNE SYSTEM |
 |
Crystal Structure Of The Therapeutic Antibody Binding Fragment Of Gevokizumab In Its Unbound State
Organism: Homo sapiens, mus musculus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2012-12-19 Classification: IMMUNE SYSTEM |
 |
Crystal Structure Of Human Il-1Beta In Complex With Therapeutic Antibody Binding Fragment Of Gevokizumab
Organism: Homo sapiens, Homo sapiens, mus musculus
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2012-12-19 Classification: IMMUNE SYSTEM |